Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
NIH
Pharma
NIH stops Xarelto arm of stroke trial due to safety, efficacy
An independent data monitoring board identified “an increase in safety events and evidence of futility” for the Xarelto arm, the NIH said.
Angus Liu
Feb 10, 2026 4:04pm
What’s ahead for biopharma and healthcare in 2026
Dec 19, 2025 10:00am
A whirlwind week for pharma
Oct 3, 2025 9:00am
HHS, NIH, CDC leaders to steer revived vaccine safety panel
Aug 14, 2025 3:52pm
Angus on Angus: A Fierce oncology discussion
Apr 25, 2025 9:41am
New NIH research on talc use poses challenge to J&J
May 22, 2024 9:20am
